Public Policy Projects (PPP) has launched a new report called ‘The Operationalisation of Precision Medicine.’ The report, which is now available to download, has been created in partnership with AstraZeneca.
Precision medicine is a development in medical history that has the potential to ensure better outcomes for patients. The UK is ahead of many countries in its expertise, ambitions, plans and infrastructure for building its research capacity and applying precision medicine to patient care. NHS in England is already on the way to developing a genomic medicine service.
However, challenges remain. The science and technology surrounding precision medicine, and demand for its tests and treatments, are advancing at such a pace that the UK is at risk of losing this edge without robust, well-funded plans for delivery and implementation.
This report features ten key recommendations for the NHS and its partners to operationalise precision medicine. The report is a product of a roundtable chaired by Rt Hon Stephen Dorrell and involves the following key speakers: Dame Professor Sue Hill, Chief Scientific Officer for England; Senior Responsible Officer for Genomics, NHS England; Dr Richard Scott, Clinical Director, Genomics England; and David Atkins PhD, Chief Executive Officer, Congenica.